New ISHLT Guidelines Support CareDx’s Monitoring and Diagnostic Solutions for Heart Transplant Patients
CareDx announced the publication of International Society for Heart and Lung Transplantation guidelines supporting its surveillance portfolio.
CareDx announced the publication of International Society for Heart and Lung Transplantation guidelines supporting its surveillance portfolio.
Genetic testing can diagnose cardiomyopathy in children and help detect who will have heart failure and require a transplant.
Digital health provider Caretaker Medical has received FDA 510(k) clearance for four new continuous hemodynamic parameters.
A genomics initiative called In Our DNA SC has been launched to improve health care outcomes by integrating genetic insights.
Read MoreNatera, Inc. has announced the validation and availability of its Prospera Heart transplant assessment test for heart transplant recipients.
Read MoreRisk for heart disease does not look the same on the genetic level for different population groups, according to researchers.
Read MoreCardiovascular genetic testing in children presents unique challenges, requiring pre- and post-test counseling with an individualized approach for families.
Read MoreResearchers conducted study to determine if providing genetic testing for patients in cardiovascular clinics would benefit clinical care.
Read MoreA new study identifies DNA signatures associated with risk for cardiovascular disease, which could lead to treatment years before symptoms.
Read MoreBeckman Coulter has definitive agreements to obtain all rights to the manufacture, distribution, and sale of a BNP assay for its analyzers.
Read MoreNew insight on the link between a gene called SORBS2 and congenital heart disease has been made and may help explain the cause of the disease.
Read MoreThe routine use of the glycosylated hemoglobin test to track blood sugar levels can identify those with more advanced atherosclerotic disease.
Read MoreQuest plans to develop a test service based on Zora’s ceramide technology as an aid in identifying patients at risk for cardiovascular-related disease and death.
Read MoreVerichem’s HDL Cholesterol Verifier Kit contains HDL and LDL cholesterol and other lipid components from human serum free of potential interfering substances.
Read MoreMyriad Genetics’ Vectra Cardiovascular Risk assessment can predict the risk for cardiovascular events in patients with rheumatoid arthritis.
Read MoreJoin Clinical Lab Products for this free webcast, sponsored by Beckman Coulter, which provides an overview of high-sensitivity troponin I testing.
Read MoreMyriad Genetics shared new data further demonstrating that Vectra testing and three additional biomarkers can help predict the risk of cardiovascular events in patients with rheumatoid arthritis.
Read MoreA noninvasive blood test may provide a ‘crystal ball’ for early detection of infections, leading to increased cure rates among pediatric leukemia patients.
Read More